BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9499037)

  • 1. Multiple functions within the Epstein-Barr virus EBNA-3A protein.
    Cludts I; Farrell PJ
    J Virol; 1998 Mar; 72(3):1862-9. PubMed ID: 9499037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B; Sample CE
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
    Harada S; Kieff E
    J Virol; 1997 Sep; 71(9):6611-8. PubMed ID: 9261383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription.
    Radkov SA; Touitou R; Brehm A; Rowe M; West M; Kouzarides T; Allday MJ
    J Virol; 1999 Jul; 73(7):5688-97. PubMed ID: 10364319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
    Jiang H; Cho YG; Wang F
    J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
    J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    Lin J; Johannsen E; Robertson E; Kieff E
    J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.
    McClellan MJ; Wood CD; Ojeniyi O; Cooper TJ; Kanhere A; Arvey A; Webb HM; Palermo RD; Harth-Hertle ML; Kempkes B; Jenner RG; West MJ
    PLoS Pathog; 2013 Sep; 9(9):e1003636. PubMed ID: 24068937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
    Bourillot PY; Waltzer L; Sergeant A; Manet E
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.
    Radkov SA; Bain M; Farrell PJ; West M; Rowe M; Allday MJ
    J Virol; 1997 Nov; 71(11):8552-62. PubMed ID: 9343213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
    Marshall D; Sample C
    J Virol; 1995 Jun; 69(6):3624-30. PubMed ID: 7745710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
    Zhao B; Marshall DR; Sample CE
    J Virol; 1996 Jul; 70(7):4228-36. PubMed ID: 8676443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes.
    Krauer KG; Kienzle N; Young DB; Sculley TB
    Virology; 1996 Dec; 226(2):346-53. PubMed ID: 8955054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
    Zimber-Strobl U; Strobl LJ; Meitinger C; Hinrichs R; Sakai T; Furukawa T; Honjo T; Bornkamm GW
    EMBO J; 1994 Oct; 13(20):4973-82. PubMed ID: 7957063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
    Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranuclear localization of the transcription coadaptor CBP/p300 and the transcription factor RBP-Jk in relation to EBNA-2 and -5 in B lymphocytes.
    Bandobashi K; Maeda A; Teramoto N; Nagy N; Székely L; Taguchi H; Miyoshi I; Klein G; Klein E
    Virology; 2001 Sep; 288(2):275-82. PubMed ID: 11601899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.
    Han I; Xue Y; Harada S; Orstavik S; Skalhegg B; Kieff E
    Mol Cell Biol; 2002 Apr; 22(7):2136-46. PubMed ID: 11884601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S; Yalamanchili R; Kieff E
    J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.
    Cooper A; Johannsen E; Maruo S; Cahir-McFarland E; Illanes D; Davidson D; Kieff E
    J Virol; 2003 Jan; 77(2):999-1010. PubMed ID: 12502816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the transcriptional repressor RBP in Epstein-Barr virus-transformed B cells.
    Krauer KG; Buck M; Sculley T
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3217-3226. PubMed ID: 10567654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.